Profile
Dr. David C.
Venables is a Chief Executive Officer & Director at Laverock Therapeutics Ltd. and a Chief Executive Officer at Synpromics Ltd. He is on the Board of Directors at Laverock Therapeutics Ltd. Dr. Venables was previously employed as a Chief Executive Officer, Director & MD by Anatara Lifesciences Ltd., a Non-Executive Director by Ark Therapeutics Group Plc, a Chief Operating Officer by Intercell USA, Inc., a Head-Process Development by Medeva Plc, and an Operations Director by Q-One Biotech Ltd. He received his doctorate degree from the University of Surrey.
David Venables active positions
| Companies | Position | Start |
|---|---|---|
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Chief Executive Officer | - |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel therapeutics for cell, gene & oncology therapeutics | Chief Executive Officer | 01/08/2021 |
Former positions of David Venables
| Companies | Position | End |
|---|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Director/Board Member | 27/02/2015 |
| ANATARA LIFESCIENCES LTD | Chief Executive Officer | 24/02/2015 |
Q-One Biotech Ltd.
Q-One Biotech Ltd. BiotechnologyHealth Technology Provides specialist safety testing, process validation, and contract manufacturing services of cell banks, vaccines and gene therapy products to the biopharmaceutical industry | Corporate Officer/Principal | - |
Medeva Plc
Medeva Plc Pharmaceuticals: MajorHealth Technology Operates as a holding company for the development, manufacture and sale of pharmaceutical products | Corporate Officer/Principal | - |
| IOMAI CORPORATION | Chief Operating Officer | - |
Training of David Venables
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Medeva Plc
Medeva Plc Pharmaceuticals: MajorHealth Technology Operates as a holding company for the development, manufacture and sale of pharmaceutical products | Health Technology |
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Discovers and develops medicinal gene-based and biological therapies and diagnostic products | Commercial Services |
Q-One Biotech Ltd.
Q-One Biotech Ltd. BiotechnologyHealth Technology Provides specialist safety testing, process validation, and contract manufacturing services of cell banks, vaccines and gene therapy products to the biopharmaceutical industry | Health Technology |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
University of Surrey
University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anatara Lifesciences Ltd.
Anatara Lifesciences Ltd. Pharmaceuticals: MajorHealth Technology Develops non-antibiotic oral solutions for gastrointestinal diseases in animals and humans | Health Technology |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Develops and commercializes synthetic promoters to control gene expressions and regulations | Process Industries |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures novel therapeutics for cell, gene & oncology therapeutics | Commercial Services |
- Stock Market
- Insiders
- David Venables
















